These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 4142544)
1. Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses. Springer GF; Desai PR Ann Clin Lab Sci; 1974; 4(4):294-8. PubMed ID: 4142544 [TBL] [Abstract][Full Text] [Related]
2. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth. Cooper AG; Codington JF; Miller DK; Brown MC J Natl Cancer Inst; 1979 Jul; 63(1):163-9. PubMed ID: 221714 [TBL] [Abstract][Full Text] [Related]
3. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma. Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825 [TBL] [Abstract][Full Text] [Related]
4. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell. Miller SC; Codington JF; Klein G J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278 [TBL] [Abstract][Full Text] [Related]
5. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA). Fung PY; Longenecker BM Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477 [TBL] [Abstract][Full Text] [Related]
6. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Galili U Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361 [TBL] [Abstract][Full Text] [Related]
7. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies. Rapp L; Fuji H Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755 [TBL] [Abstract][Full Text] [Related]
8. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays. Lopez PF; Parks WP; Lopez DM J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544 [TBL] [Abstract][Full Text] [Related]
9. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. Springer GF; Desai PR; Banatwala I J Natl Cancer Inst; 1975 Feb; 54(2):335-9. PubMed ID: 163330 [TBL] [Abstract][Full Text] [Related]
10. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice. Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191 [TBL] [Abstract][Full Text] [Related]
11. Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection. Codington JF; Das HR; Dalianis T; Klein G; Miller SC; Silber C; Lampert LA; Darby DM; Jeanloz RW Cancer Res; 1983 Sep; 43(9):4373-81. PubMed ID: 6871870 [TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of Vicia graminea lectin- and Vicia unijuga lectin-binding glycoproteins in human tumor and nontumor cells and an estimation of its epitope structure. Ohyama K; Uchide N; Suzuki R; Iwamoto N; Bessho T; Watanabe H; Hirakawa S; Yamakawa T Cancer Detect Prev; 2000; 24(1):61-71. PubMed ID: 10757124 [TBL] [Abstract][Full Text] [Related]
13. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A. Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the T antigen and T agglutinin in inbred rats. Noeman SA; Misra DN; Gill TJ Immunology; 1980 Feb; 39(2):219-29. PubMed ID: 6155326 [TBL] [Abstract][Full Text] [Related]
15. The integrin alpha 6 beta 4 on TA3/Ha mammary carcinoma cells is involved in adhesion to hepatocytes. Kemperman H; Wijnands Y; de Rijk D; Roos E Cancer Res; 1993 Aug; 53(15):3611-7. PubMed ID: 8339267 [TBL] [Abstract][Full Text] [Related]
16. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Yu L; Fernig DG; Smith JA; Milton JD; Rhodes JM Cancer Res; 1993 Oct; 53(19):4627-32. PubMed ID: 8402638 [TBL] [Abstract][Full Text] [Related]
17. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. LaTemple DC; Abrams JT; Zhang SY; Galili U Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604 [TBL] [Abstract][Full Text] [Related]
18. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. Cayeux S; Richter G; Noffz G; Dörken B; Blankenstein T J Immunol; 1997 Mar; 158(6):2834-41. PubMed ID: 9058819 [TBL] [Abstract][Full Text] [Related]
19. Viral aetiopathogenesis of tumors. Klein E Boll Ist Sieroter Milan; 1971; 50(3):140-51. PubMed ID: 4111986 [No Abstract] [Full Text] [Related]
20. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency. Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]